We are live on ! Find out more
DMRA

Damora Therapeutics, Inc. Ordinary Shares
DMRA

19 hedge funds and large institutions have $175M invested in Damora Therapeutics, Inc. Ordinary Shares in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.23% more ownership

Funds ownership: 0% → 2.23% (+2.2%)

Holders
19
Holders Change
+19
Holders Change %
–
% of All Funds
0.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$60.9M
2
NHAS
Novo Holdings A/S
Denmark
+$37.2M
3
CAM
Cormorant Asset Management
Massachusetts
+$32M
4
SCM
Soleus Capital Management
Connecticut
+$22.5M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$19.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$51.2M +$60.9M +163,637 New
NHAS
2
Novo Holdings A/S
Denmark
$31.2M +$37.2M +99,912 New
CAM
3
Cormorant Asset Management
Massachusetts
$26.5M +$32M +86,029 New
SCM
4
Soleus Capital Management
Connecticut
$18.9M +$22.5M +60,506 New
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$15.9M +$19.9M +53,423 New
BlackRock
6
BlackRock
New York
$8.19M +$9.74M +26,195 New
MC
7
Maverick Capital
Texas
$5.85M +$7.3M +19,618 New
SFM
8
Sphera Funds Management
Israel
$4.67M +$5.83M +15,671 New
ACM
9
Asymmetry Capital Management
California
$4.22M +$5.02M +13,494 New
LCM
10
Laurion Capital Management
New York
$2.59M +$3.09M +8,302 New
Fidelity Investments
11
Fidelity Investments
Massachusetts
$1.67M +$1.98M +5,333 New
MIM
12
Monashee Investment Management
Massachusetts
$1.05M +$1.25M +3,367 New
Millennium Management
13
Millennium Management
New York
$875K +$1.04M +2,800 New
Tudor Investment Corp
14
Tudor Investment Corp
Connecticut
$806K +$958K +2,577 New
WMSA
15
Weiss Multi-Strategy Advisers
New York
$515K +$612K +1,646 New
CCM
16
CAAS Capital Management
New York
$250K +$298K +800 New
Federated Hermes
17
Federated Hermes
Pennsylvania
$250K +$298K +800 New
Bank of America
18
Bank of America
North Carolina
$56K +$67K +180 New
Morgan Stanley
19
Morgan Stanley
New York
$13K +$14.9K +40 New

DMRA Hedge Fund Activity: Q4 2020 in Review

19 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) for Q4 2020, worth a combined $175M.

Buyers outnumbered sellers: 19 funds opened new DMRA positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $60.9M.

  • 19 institutional investors held Damora Therapeutics, Inc. Ordinary Shares (DMRA) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $175M of Damora Therapeutics, Inc. Ordinary Shares stock for Q4 2020.
  • 19 funds opened new Damora Therapeutics, Inc. Ordinary Shares positions in Q4 2020 and 0 closed out, a net change of +19 holders.
  • The largest Damora Therapeutics, Inc. Ordinary Shares buyer in Q4 2020 was OrbiMed, an estimated $60.9M added.

Based on aggregated 13F filings for Q4 2020.